Triple Pill. Tighter Pressure. Fewer Strokes. 🧠💊📉

A simple idea, executed elegantly.   In the NEJM TRIDENT trial, a single low-dose triple antihypertensive pill reduced recurrent stroke after intracerebral hemorrhage (HR 0.61) and improved BP control (50% vs 26%).   Yet, only half reached target—reminding us that pills alone don't solve therapeutic inertia.   The message is clear: simplify treatment, intensify targets, and build systems that ensure control.   One pill helps. Systems save lives. 💊📉🧠